Atlas Trials

A Study to Compare MitoQ and Placebo to Treat Non-alcoholic Fatty Liver Disease (NAFLD)

Clinical trial NCT01167088 · TERMINATED

Trial details

NCT number
NCT01167088
Sponsor
Antipodean Pharmaceuticals, Inc.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Non-alcoholic Fatty Liver Disease
Start date
2010-11-01
Primary completion
2011-06-01
Enrollment
110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.